doi:10.1177/20420188231222367 GorgojoMartnez JJ, MezquitaRaya P, CarreteroGmez J, Castro A, CebrinCuenca A, de TorresSnchez A, GarcadeLucas MD, Nez J, Obaya JC, Soler MJ
Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder and as add-on to insulin for type 1 diabetes
Maintaining a consistent weekly schedule is generally the safest approach unless a healthcare professional advises otherwise
Tracking Key Performance Metrics to Optimize Revenue Regularly monitoring performance metrics helps clinics refine their GLP-1 program and maximize profitability